Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VBI Vaccines
Pharma
VBI recalls hepatitis B shot as it winds down operations
The company initiated a voluntary recall of its sole commercial product after filing for Chapter 15 bankruptcy earlier this year.
Zoey Becker
Nov 18, 2024 10:42am
Takeda, WuXi, LianBio—Fierce Pharma Asia
Feb 16, 2024 8:24am
VBI Vaccines shrinks 'long-term burn' with $33M Brii Bio deal
Feb 14, 2024 11:12am
AZ-Daiichi, Moderna, Takeda and more—Fierce Pharma Asia
Jul 7, 2023 9:45am
EMA expands nods for BMS, Eli Lilly, Novartis drugs
Feb 25, 2022 11:42am
FDA approves VBI's PreHevbrio just as HBV market is set to grow
Dec 1, 2021 10:34am
